Update: nrx pharmaceuticals (nasdaq: nrxp) to report fourth quarter and full year 2023 financial results on march 28, 2024

Radnor, pa., march 26, 2024 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals", the "company"), a clinical-stage biopharmaceutical company, today announced that it will release its fourth quarter and full year 2023 financial results after the market closes on thursday, march 28, 2024, via press release, which will be available on the company's website at https://ir.nrxpharma.com/press-releases.
NRXP Ratings Summary
NRXP Quant Ranking